Spots Global Cancer Trial Database for Evaluation of Pigmented Skin Lesions With MelaFind(R) System
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Pigmented Skin Lesions With MelaFind(R) System
Official Title: Evaluation of Pigmented Skin Lesions With MelaFind(R) System
Study ID: NCT00434057
Conditions
Interventions
Study Description
Brief Summary: The purpose of this clinical trial is to demonstrate that MelaFind®, a new instrument that uses machine vision for non-invasive early detection of cutaneous pigmented malignant melanoma, is safe and effective. MelaFind® acquires digital images of the lesion with illumination in different spectral bands, from visible to near infrared, and automatically analyzes these images. Diagnostic accuracy of MelaFind® and that of study dermatologists will be evaluated. The reference standard will be final interpretation of lesions by central dermatohistopathology.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Skin and Cancer Associates, Plantation, Florida, United States
Dermatology Associates of Tallahassee, Tallahassee, Florida, United States
Contact Details
Name: Dina Gutkowicz-Krusin, PhD
Affiliation: Electro-Optical Sciences, Inc.
Role: STUDY_DIRECTOR
Name: Joseph V Gulfo, MD, MBA
Affiliation: Electro-Optical Sciences, Inc.
Role: STUDY_DIRECTOR
Name: Harold S Rabinovitz, MD
Affiliation: Skin and Cancer Associates
Role: STUDY_CHAIR
Name: Armand B Cognetta, Jr, MD
Affiliation: Dermatology Associates of Tallahassee
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
